Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | STS | P08842 | 1/20 | 0.31 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.31 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 2/20 | 0.30 |
| ▸ | HTR1D | P28221 | 2/20 | 0.30 |
| ▸ | HTR1B | P28222 | 2/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23871320 | 0.88 | CA1 (0.32) | CA1CA2STSPTPN7DUSP3 | |
| SCHEMBL23871155 | 0.82 | PTPN7 (0.36) | PTPN7DUSP3PTPN12PTPN22 | |
| SCHEMBL23664765 | 0.81 | DUSP3 (0.40) | CA1CA2STSPTPN7DUSP3 | |
| SCHEMBL23975322 | 0.79 | CA1 (0.32) | CA1CA2HTR1AHTR1DHTR1B | |
| SCHEMBL23871157 | 0.78 | STS (0.32) | STSPTPN7DUSP3PTPN12PTPN22 | |
| SCHEMBL23861346 | 0.76 | PTPN7 (0.38) | CA1CA2STSPTPN7DUSP3 | |
| SCHEMBL17987436 | 0.75 | GPR3 (0.38) | PTPN7DUSP3PTPN12PTPN22 | |
| SCHEMBL18928038 | 0.73 | KDM4E (0.33) | — | |
| SCHEMBL21989586 | 0.70 | GPR3 (0.39) | DUSP3PTPN12 | |
| SCHEMBL14032144 | 0.70 | DRD2 (0.41) | CA1CA2STSHTR1AHTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11358946-B2 | Compound for organic electronic element, organic electronic element using same and electronic device therefor | DUK SAN NEOLUX CO., LTD. | 2022-06-14 | — | — | US | disclosed |
| US-20210300888-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD (KR) | 2021-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11358946-B2 | Compound for organic electronic element, organic electronic element using same and electronic device therefor | OR51E2, SLC39A11, WEE1 | CA1 2032/4885CA2 2472/4885STS 3340/4885 |
| US-20210300888-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | OR51E2, SLC39A11, WEE1 | CA1 2032/4885CA2 2472/4885STS 3340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.